Home > Insider Trading > Filing (0001181431-11-050461)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1371217	Enteromedics Inc	ETRM	Electromedical & Electrotherapeutic Apparatus (3845)	000000000

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1288452	Bay City Capital Llc	750 Battery Street Suite 400 San Francisco CA 94111	No	No	Yes	No
1333817	Bay City Capital Fund Iv Co Invesment Fund Lp	750 Battery Street Suite 400 San Francisco CA 94111	No	No	Yes	No
1359070	Bay City Capital Management Iv Llc	750 Battery Street Suite 400 San Francisco CA 94111	No	No	Yes	No
1360243	Bay City Capital Fund Iv, L.p.	C/O Bay City Capital Llc 750 Battery Street, Suite 400 San Francisco CA 94111	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-09-23	822,276	$1.65	4,800,964	No	4	P	Direct
Common Stock	Acquisiton	2011-09-23	17,724	$1.65	103,484	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Common Stock Warrant	Acquisiton	2011-09-23	164,455	$0.00	164,455	$1.90
Common Stock	Common Stock Warant	Acquisiton	2011-09-23	3,545	$0.00	3,545	$1.90

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
3,563,814	2011-09-23	2016-09-28	No	4	P	Direct
76,817	2011-09-23	2016-09-28	No	4	P	Direct

Footnotes

Bay City Capital Fund IV, L.P. ("Fund IV"), Bay City Capital Fund IV Co-Investment Fund, L.P. ("Co-Investment IV"), Bay City Capital Management IV LLC ("Management IV") and Bay City Capital LLC ("BCC") are deemed to be a "group" for the purpose of Section 13(d) under the Securities Exchange Act of 1934.
Represent shares held by Fund IV; and indirect interests of BCC, the manager of Management IV, and Management IV, the general partner of Fund IV. BCC and Management IV each disclaims beneficial ownership is such shares, except to the extent of their pecuniary interest therein.
Represent shares held by Co-Investment IV; and indirect interests of BCC, the manager of Management IV, and Management IV, the general partner of Co-Investment IV. BCC and Management IV each disclaims beneficial ownership in such shares, except to the extent of their pecuniary interest therein.